Hoey Investments Inc. Acquires 4,273 Shares of iShares Biotechnology ETF $IBB

Hoey Investments Inc. raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1,818.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,508 shares of the financial services provider’s stock after acquiring an additional 4,273 shares during the period. Hoey Investments Inc.’s holdings in iShares Biotechnology ETF were worth $761,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Webster Bank N. A. grew its position in iShares Biotechnology ETF by 1.0% during the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after acquiring an additional 62 shares during the last quarter. Choreo LLC grew its position in iShares Biotechnology ETF by 2.2% during the fourth quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock valued at $514,000 after acquiring an additional 65 shares during the last quarter. HB Wealth Management LLC grew its position in iShares Biotechnology ETF by 1.4% during the fourth quarter. HB Wealth Management LLC now owns 4,699 shares of the financial services provider’s stock valued at $793,000 after acquiring an additional 66 shares during the last quarter. Close Asset Management Ltd grew its position in iShares Biotechnology ETF by 25.5% during the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock valued at $50,000 after acquiring an additional 70 shares during the last quarter. Finally, Bigelow Investment Advisors LLC grew its holdings in shares of iShares Biotechnology ETF by 2.1% in the fourth quarter. Bigelow Investment Advisors LLC now owns 3,572 shares of the financial services provider’s stock worth $603,000 after purchasing an additional 74 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $171.53 on Friday. iShares Biotechnology ETF has a 52-week low of $116.25 and a 52-week high of $179.64. The company’s 50 day moving average price is $170.40 and its 200-day moving average price is $167.81.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were issued a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 annualized dividend and a dividend yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.